SCHEMBL7872005

SCHEMBL7872005

CC(C)(C)OC(=O)N1CCC(C(S)Cc2ccccc2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 5/20 0.61
▸ STS P08842 1/20 0.56
▸ KDM4E B2RXH2 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ YAP1 P46937 3/20 0.52
▸ DPP4 P27487 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ JAK2 O60674 1/20 0.50
▸ JAK1 P23458 1/20 0.50
▸ MAPK1 P28482 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ GPR55 Q9Y2T6 1/20 0.48
▸ KEAP1 Q14145 1/20 0.48
▸ NFE2L2 Q16236 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4118016 0.88 GPR119 (0.61) GPR119STSKDM4EPKMYAP1
SCHEMBL22750432 0.83 GPR119 (0.59) GPR119STSKDM4EPKMYAP1
SCHEMBL23751448 0.83 GPR119 (0.59) GPR119STSKDM4EPKMYAP1
SCHEMBL22750429 0.83 GPR119 (0.59) GPR119STSKDM4EPKMYAP1
SCHEMBL22750434 0.83 GPR119 (0.59) GPR119STSKDM4EPKMYAP1
SCHEMBL2101091 0.82 STS (0.55) GPR119STSKDM4EPKMYAP1
SCHEMBL7972888 0.81 GPR119 (0.68) GPR119STSKDM4EPKMYAP1
SCHEMBL7863097 0.81 GPR119 (0.59) GPR119STSKDM4EPKMDPP4
SCHEMBL7588645 0.80 GPR119 (0.61) GPR119STSKDM4EPKMYAP1
SCHEMBL31120243 0.80 GPR119 (0.53) GPR119STSKDM4EPKMYAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 — — US disclosed
WO-2000051608-A1 3-THIENYL AND 3-FURANYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 — — WO disclosed
Send feedback